Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
6d
HealthDay on MSNFDA Approves TNKase for Acute Ischemic StrokeThe U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, f ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators ...
Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...
The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...
The National Childhood Vaccine Injury Act of 1986 removed the economic incentive that held vaccine developers accountable for vaccine safety. Reforms, including properly designed trials, are needed to ...
Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results